MD
Medically Reviewed & Fact-Checked
E-E-A-T VerifiedAll answers conform to current clinical data and ethical parameters under the National Guidelines for Stem Cell Research (ICMR-DBT).
1. Cellular Biology & Fundamentals
Stem cells are primitive, undifferentiated biological cells that possess the unique capabilities of self-renewal (dividing indefinitely) and differentiation into specialized cell types such as neural progenitors, cardiomyocytes, or osteocytes. In regenerative therapy, they stimulate endogenous repair mechanisms and modulate immune responses.
Yes, 100% ethically sourced. We utilize two validated cell categories:
- Autologous: Harvested safely from the patient's own bone marrow or adipose tissue.
- Allogeneic: Screened Mesenchymal Stem Cells sourced from donated human umbilical cord Wharton's Jelly following healthy, full-term cesarean births with voluntary maternal consent.
No, absolutely not. We do not use embryonic or fetal cells due to ethical considerations and documented risks of teratoma formation. We only work with adult and post-natal tissue-derived stem cells.
In compliance with ethical medical practice, stem cell therapy should not be represented as a guaranteed 100% cure for chronic degenerative diseases. Rather, the clinical objective is symptom reduction, preservation of organ function, halting disease progression, and substantially enhancing quality of life.
2. Clinical Eligibility & Disease Indications
Our partner hospitals manage clinical protocols across four major areas:
- Neurological: ALS/MND, Cerebral Palsy, Stroke Rehabilitation, Ataxia, Spinal Cord Injury.
- Organ & Metabolic: Chronic Kidney Disease, Type 2 Diabetes, Liver Cirrhosis.
- Orthopedic: Osteoarthritis (knee/hip), Cartilage defects, Avascular Necrosis.
- Autoimmune: Multiple Sclerosis, Rheumatoid Arthritis, Lupus.
Patients with active malignancies cannot receive mesenchymal regenerative therapy because growth factors released by stem cells could potentially encourage tumor growth. Only patients in confirmed, documented long-term remission may be considered after comprehensive oncology clearance.
You submit recent diagnostic imaging (MRI/CT), clinical discharge summaries, and blood work via our confidential portal. Our medical advisory board audits your records against inclusion/exclusion criteria and responds with an official evaluation within 24 business hours.
3. Procedure, Administration & Safety
Delivery methods are selected according to condition pathology:
- Intravenous (IV) Infusion: For systemic, autoimmune, and metabolic indications.
- Intrathecal (Lumbar Puncture): Directly into the cerebrospinal fluid for neurological disorders crossing the blood-brain barrier.
- Intra-articular Injection: Targeted directly into damaged knee, hip, or shoulder joints.
Stem cell therapy has a well-documented clinical safety profile. Recognized temporary side effects include mild transient low-grade fever, headache, or localized soreness at the injection site that resolves spontaneously within 24 to 48 hours.
All cells are processed in ISO-certified Class 10,000 cGMP cleanrooms. Every therapeutic dose is verified via automated flow cytometry to ensure >90% cell viability, negative bacterial/fungal cultures, and endotoxin levels far below international pharmacopeia limits.
4. Costs, International Travel & Legal Framework
India's lower healthcare infrastructure overhead, government-supported pharmaceutical biotechnology manufacturing, and lower cost of clinical personnel enable savings of 60% to 75% compared to Western nations while adhering to identical international cGMP standards.
Once your treatment dates are finalized, our hospital desk issues an official Medical Visa Invitation Letter on hospital letterhead. You can apply for an Indian e-Medical Visa online, which is typically granted within 72 to 96 hours.
Our international care coordinators conduct structured tele-consultations at the 1-month, 3-month, and 6-month post-procedure intervals to monitor biomarker changes, functional rehabilitation progress, and coordinate with your hometown physician.
Check Treatment Eligibility
Confidential case review by our medical board within 24 business hours.